• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROSA VALVE W/DIST.CATHETER; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROSA VALVE W/DIST.CATHETER; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV706T
Device Problem Infusion or Flow Problem (2964)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 01/09/2020
Event Type  Injury  
Manufacturer Narrative
Height: 160cm.Implant date: 2013 (unknown month and day).When additional information becomes available a follow up report will be submitted.
 
Event Description
It was reported the valve was not adjustable.The reporter indicated that an approximately 6 year old post-operative valve was not able to be adjusted and required explantation.Additional information was not provided.
 
Manufacturer Narrative
Investigation.Visual inspection: no significant deformations or damage of the valves were detected during the visual inspection.The progav valve housing was subsequently measured and indicated the presence of a slight deformation.The housing deformation measured at -0.068mm, outside the tolerance of 0 +/- 0.02mm.Permeability test: a permeability test has shown that the progav valve is permeable.Adjustment test: the progav valve was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational.However, the braking force required is not within the specified tolerances.Computer controlled test: to investigate the claim of malfunction, the opening pressure is measured using a miethke computer controlled testing apparatus, which simulates a cerebrospinal fluid flow.The progav valve is operating within acceptable tolerances.Finally, we have dismantled the valves.There were no visible deposits observed inside the valve.Based on our investigation, we are unable to substantiate the claim of malfunction.At the time of our investigation, the progav valve operated as expected, but due to the reduced braking force, it could have temporarily led to an unintentional and spontaneous adjustment of the valve.In addition, it is possible that the deposits observed inside the valve could have caused the malfunction in the past, too.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.The cause of the deformation of the progav valve and the resultant reduced braking force could not be determined through our investigation.However, we would like to point out that significant outside pressure, for example by too much force from the progav adjustment tool or by a fall or impact to the head of the patient, can compromise the integrity of the valve.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROSA VALVE W/DIST.CATHETER
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key9597761
MDR Text Key187269840
Report Number3004721439-2020-00019
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K120559
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/16/2016
Device Model NumberFV706T
Device Catalogue NumberFV706T
Device Lot Number20015568
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/10/2020
Date Manufacturer Received01/29/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age29 YR
Patient Weight90
-
-